ADVM logo

Adverum Biotechnologies, Inc. (ADVM)

Profile

Full Name

Adverum Biotechnologies, Inc.

Ticker

NASDAQ: ADVM

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 31, 2014

Indexes

Not included

Website

http://adverum.com

Employees

155

Key Details

Price

$2.39(-3.24%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.00M(-72.22% YoY)

Annual EPS

-$6.62(+45.33% YoY)

PE ratio

-

Next earnings date

Aug 12, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.39
    ADVM price is $2.39

    30-Day Relative Volume

    0.34
    ADVM 30-day relative volume is 0.34

    Price Performance

    Price Today change

    -3.24%
    ADVM price is down -3.24% today

    Price YTD change

    -48.82%
    ADVM price is down -48.82% since January 1st

    Price 1-year change

    -67.79%
    ADVM price is down -67.79% year-on-year

    Price 3-year change

    -83.63%
    ADVM price is down -83.63% over the past 3 years

    Price Range

    Price All-time high

    $624.80
    ADVM price is currently -99.62% below its historical high of $624.80

    Price 3-year low

    $1.78
    ADVM price is currently +34.27% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $49.93M
    ADVM market capitalization is $49.93 million

    Market cap 3-year change

    -65.55%
    ADVM market capitalization is down -65.55% over the past 3 years

    Market cap All-time high

    $2.06B
    ADVM market capitalization is currently -97.57% below its historical high of $2.06 billion

    Market cap sector rank

    33.72%
    ADVM market capitalization is higher than 33.72% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.43%
    ADVM shares outstanding is up +0.43% year-on-year

    Shares Outstanding 3-Year Change

    +110.44%
    ADVM shares outstanding is up +110.44% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.36
    ADVM beta is 1.36

    200-day SMA

    $4.39
    ADVM price is currently -45.54% below its 200-day simple moving average

    50-day SMA

    $2.48
    ADVM price is currently -3.64% below its 50-day simple moving average

    RSI

    42.45
    ADVM 14-day relative strength index is 42.45

    Volume

    0.34
    ADVM 30-day relative volume is 0.34

    ATR

    $0.22
    ADVM average true range is $0.22

    10-day Historical Volatility

    42.87%
    ADVM 10-day historical volatility is 42.87%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $1.00M
    ADVM annual revenue is $1.00 million

    Revenue Analysts estimate

    $12.66M
    ADVM annual revenue is currently -92.10% lower than the consensus analysts' forecast

    Revenue 1-year change

    -72.22%
    ADVM annual revenue is down -72.22% year-on-year

    Revenue Sector rank

    12.56%
    ADVM annual revenue is higher than 12.56% of companies in Healthcare sector

    EPS

    EPS

    -$6.62
    ADVM annual earnings per share is -$6.62

    EPS Analysts estimate

    -$5.20
    ADVM annual earnings per share is currently +27.21% higher than the consensus analysts' forecast

    EPS 1-year change

    +45.33%
    ADVM annual earnings per share is up +45.33% year-on-year

    EPS Sector rank

    17.1%
    ADVM annual earnings per share is higher than 17.1% of companies in Healthcare sector

    Profit

    Gross profit

    -
    ADVM annual gross profit value is unknown

    Gross margin

    -
    ADVM annual gross profit margin value is unknown

    Operating profit

    -$139.16M
    ADVM annual operating income is -$139.16 million

    Operating margin

    -13.92K%
    ADVM annual operating profit margin is -13.92 thousand%

    Net income

    -$130.93M
    ADVM annual net profit is -$130.93 million

    Net margin

    -13.09K%
    ADVM annual net profit margin is -13.09 thousand%

    Expenses

    Total expenses

    $140.16M
    ADVM annual total expenses is $140.16 million

    Operating expenses

    $140.16M
    ADVM annual total operating expenses is $140.16 million

    Cost of goods sold

    -
    ADVM annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $63.12M
    ADVM annual SGA is $63.12 million

    Depreciation and amortization

    $3.65M
    ADVM annual depreciation & amortization is $3.65 million

    Interest expense

    -
    ADVM annual interest expense value is unknown

    Income tax

    $0.00
    ADVM annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$139.16M
    ADVM annual earnings before interest & taxes is -$139.16 million

    EBITDA

    -$135.51M
    ADVM annual EBITDA is -$135.51 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $179.84M
    ADVM annual total assets is $179.84 million

    Non current assets

    $48.54M
    ADVM annual long term assets is $48.54 million

    Current assets

    $131.30M
    ADVM annual total current assets is $131.30 million

    Cash and cash equivalents

    $60.65M
    ADVM annual cash & cash equivalents is $60.65 million

    Accounts receivable

    -
    ADVM annual accounts receivable value is unknown

    Inventory

    -
    ADVM annual inventory value is unknown

    Liabilities

    Total liabilities

    $109.13M
    ADVM annual total liabilities is $109.13 million

    Long term liabilities

    $86.23M
    ADVM annual total long term liabilities is $86.23 million

    Current liabilities

    $22.90M
    ADVM annual total current liabilities is $22.90 million

    Accounts payable

    $1.61M
    ADVM annual accounts payable is $1.61 million

    Debt

    Total debt

    $91.70M
    ADVM annual total debt is $91.70 million

    Total debt 1-year change

    +23.86%
    ADVM annual total debt is up +23.86% year-on-year

    Long term debt

    $86.04M
    ADVM annual long term debt is $86.04 million

    Short term debt

    $5.67M
    ADVM annual short term debt is $5.67 million

    Equity & Capital

    Shareholders equity

    $70.71M
    ADVM annual stockholders equity is $70.71 million

    Book value

    $70.71M
    ADVM annual book value is $70.71 million

    Retained earnings

    -$1.07B
    ADVM annual retained earnings is -$1.07 billion

    Working capital

    $108.40M
    ADVM annual working capital is $108.40 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$92.46M
    ADVM annual cash flow from operations is -$92.46 million

    Cash from operations 1-year change

    -1.72%
    ADVM annual cash flow from operations is down -1.72% year-on-year

    Cash from investing

    -$41.89M
    ADVM annual cash flow from investing activities is -$41.89 million

    Cash from investing 1-year change

    -143.24%
    ADVM annual cash flow from investing activities is down -143.24% year-on-year

    Cash from financing

    $120.00M
    ADVM annual cash flow from financing activities is $120.00 million

    Cash from financing 1-year change

    +173817.39%
    ADVM annual cash flow from financing activities is up +173817.39% year-on-year

    CAPEX

    CAPEX

    $388.00K
    ADVM annual capital expenditures is $388.00 thousand

    CAPEX 1-year change

    -51.98%
    ADVM annual capital expenditures is down -51.98% year-on-year

    Free Cash Flow

    Free cash flow

    -$92.85M
    ADVM annual free cash flow is -$92.85 million

    Free cash flow 1-year change

    -1.24%
    ADVM annual free cash flow is down -1.24% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    ADVM annual gross profit margin value is unknown

    Operating margin

    -13.92K%
    ADVM annual operating profit margin is -13.92 thousand%

    Net margin

    -13.09K%
    ADVM annual net profit margin is -13.09 thousand%

    ROA & ROE

    ROA

    -78.02%
    ADVM annual return on assets is -78.02%

    ROE

    -189.84%
    ADVM annual return on equity is -189.84%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ADVM price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ADVM price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.89
    ADVM price to book ratio is 1.89

    PB ratio Sector rank

    54.76%
    ADVM price to book ratio is higher than 54.76% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    ADVM price to sales ratio value is unknown

    PS ratio Sector rank

    -
    ADVM price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $93.95M
    ADVM enterprise value is $93.95 million

    Enterprise value Sector rank

    43.57%
    ADVM enterprise value is higher than 43.57% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.60
    ADVM EV/EBITDA is -0.60

    EV/EBITDA Sector rank

    55.24%
    ADVM EV/EBITDA is higher than 55.24% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    5.73
    ADVM annual current ratio is 5.73

    Quick ratio

    -
    ADVM annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    ADVM annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    ADVM annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    ADVM piotroski f-score value is unknown

    Altman Z-Score

    -9.86
    ADVM altman z-score is -9.86

    Analyst ratings

    Recent major analysts updates

    Jun 26, 25 Mizuho
    Outperform
    May 15, 25 RBC Capital
    Sector Perform
    May 15, 25 HC Wainwright & Co.
    Buy
    May 15, 25 Chardan Capital
    Buy
    Apr 17, 25 Chardan Capital
    Buy
    Apr 16, 25 RBC Capital
    Sector Perform
    Apr 16, 25 HC Wainwright & Co.
    Buy
    Nov 19, 24 HC Wainwright & Co.
    Buy
    Nov 5, 24 RBC Capital
    Sector Perform
    Aug 14, 24 Truist Securities
    Buy

    Institutional Ownership

    Screeners with ADVM included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Adverum Biotechnologies, Inc.?
    • Does Adverum Biotechnologies, Inc. pay dividends?
    • What sector is Adverum Biotechnologies, Inc. in?
    • What industry is Adverum Biotechnologies, Inc. in?
    • What country is Adverum Biotechnologies, Inc. based in?
    • When did Adverum Biotechnologies, Inc. go public?
    • Is Adverum Biotechnologies, Inc. in the S&P 500?
    • Is Adverum Biotechnologies, Inc. in the NASDAQ 100?
    • Is Adverum Biotechnologies, Inc. in the Dow Jones?
    • When was Adverum Biotechnologies, Inc.'s last earnings report?
    • When does Adverum Biotechnologies, Inc. report earnings?

    What is the ticker symbol for Adverum Biotechnologies, Inc.?

    The ticker symbol for Adverum Biotechnologies, Inc. is NASDAQ:ADVM

    Does Adverum Biotechnologies, Inc. pay dividends?

    No, Adverum Biotechnologies, Inc. does not pay dividends

    What sector is Adverum Biotechnologies, Inc. in?

    Adverum Biotechnologies, Inc. is in the Healthcare sector

    What industry is Adverum Biotechnologies, Inc. in?

    Adverum Biotechnologies, Inc. is in the Biotechnology industry

    What country is Adverum Biotechnologies, Inc. based in?

    Adverum Biotechnologies, Inc. is headquartered in United States

    When did Adverum Biotechnologies, Inc. go public?

    Adverum Biotechnologies, Inc.'s initial public offering (IPO) was on July 31, 2014

    Is Adverum Biotechnologies, Inc. in the S&P 500?

    No, Adverum Biotechnologies, Inc. is not included in the S&P 500 index

    Is Adverum Biotechnologies, Inc. in the NASDAQ 100?

    No, Adverum Biotechnologies, Inc. is not included in the NASDAQ 100 index

    Is Adverum Biotechnologies, Inc. in the Dow Jones?

    No, Adverum Biotechnologies, Inc. is not included in the Dow Jones index

    When was Adverum Biotechnologies, Inc.'s last earnings report?

    Adverum Biotechnologies, Inc.'s most recent earnings report was on May 14, 2025

    When does Adverum Biotechnologies, Inc. report earnings?

    The next expected earnings date for Adverum Biotechnologies, Inc. is August 12, 2025
    On this page